Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-14-059112
Filing Date
2014-09-22
Accepted
2014-09-22 20:13:43
Documents
1
Period of Report
2014-09-19

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 11775
  Complete submission text file 0001209191-14-059112.txt   13254
Mailing Address C/O SGX PHARMACEUTICALS, INC. 10505 ROSELLE STREET SAN DIEGO CA 92121
Business Address
GREY MICHAEL G (Reporting) CIK: 0001240122 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-35238 | Film No.: 141114964

Mailing Address ADELAIDE CHAMBERS PETER STREET DUBLIN L2 8
Business Address ADELAIDE CHAMBERS PETER STREET DUBLIN L2 8 011-353-1-649-8521
Horizon Pharma plc (Issuer) CIK: 0001492426 (see all company filings)

EIN.: 272179987 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations